While antiviral drugs are widely available, the researchers say they are underused, perhaps because patients fear viral rebound after treatment.
Reviews uncover no consistent link between antiviral drugs like Paxlovid and COVID rebound
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients
- COVID-19 linked to increased preterm birth, other problems in pregnancy